British Journal of Dermatology

Papers
(The H4-Index of British Journal of Dermatology is 43. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Integrating artificial intelligence into skin cancer pathways: the opportunities and obstacles308
Greater understanding about differences in the long-term course of eczema and their risk factors in children226
Epidemiology, comorbidities and mortality of pyoderma gangrenosum: new insights177
520 - Evaluating the expression of OX40 and OX40 ligand in lesional skin versus non-lesional skin in volunteers with atopic dermatitis and in healthy control skin107
561 - Dupilumab treatment reduces signs in patients with atopic hand and foot dermatitis: results from a phase 3, randomized, double-blind, placebo-controlled trial104
Higher proportion of cellulitis in severe lymphoedema101
一项在一家大型教学医院进行的 5 年皮肤附属器肿瘤研究, 对关联基因诊断提供了启示88
对化疗所致脱发的更深入了解84
P100: Efficacy of current treatments under study in patients with alopecia areata79
空气污染会导致皮肤颜色变深79
Recognizing psoriasis in children and adolescents: the DIPSOC study78
BH13: Scarring alopecia affecting a congenital melanocytic naevus in a patient with frontal fibrosing alopecia77
P15: Twenty years of the UK Dermatology Clinical Trials Network: past, present and future72
P57: New order: redesigning referral pathways to improve access for patients from dermatology outpatient waiting lists72
CPC11: Bromoderma in a patient with chronic obstructive pulmonary disease72
P52: Opportunities for implementing a patient‐initiated follow‐up pathway in patients with psoriasis completing narrowband ultraviolet B phototherapy67
开展健康宣传活动，禁售日光浴床，以减少皮肤癌: 合理利用医疗预算67
BH09: Frontal fibrosing alopecia in men: is it any different?67
H10: A Sweet diagnosis to make: the history of Robert Douglas Sweet and acute febrile neutrophilic dermatosis67
Issue Information66
News and Notices65
Possible new oral treatment for hidradenitis suppurativa62
DP27: Maculopapular cutaneous mastocytosis mimicking seborrhoeic folliculitis60
P53: Office 365: Microsoft Lists as a tool for a secure online second‐line/systemic drug database59
皮肤红斑狼疮治疗指南56
P91: Cutaneous adverse events of immune check point inhibitors nivolumab, pembrolizumab and atezolizumab: a multicentric study56
DP12: An 11‐year mystery56
Editor's Choice – John Ingram – Sep 202354
银屑病皮肤细胞中的小分子 RNA 促进炎症发生54
Can brepocitinib be formulated into an effective topical therapy to treat mild-to-moderate chronic plaque psoriasis?54
Correction53
O22 Unravelling the pathophysiology of KLICK syndrome to identify therapeutically targetable pathways52
Dupilumab improves patient-reported symptoms and health-related quality of life in children aged 6–11 years with severe atopic dermatitis51
Incidence, mortality and survival in people with Merkel cell carcinoma: a systematic review51
Adding up the desmosomal genes causing syndromes with hair and skin involvement: identification of TUFT1 by state-of-the-art whole-genome sequencing50
Development of a shared decision-making tool in vitiligo: an international study50
Multicentre phase II trial of plasminogen activator inhibitor-1 inhibitor (TM5614) plus nivolumab in Japanese advanced melanoma patients: immune resistance remains one of the major efforts in melanoma47
Comparison of incidence, causes and prognosis of adult and paediatric epidermal necrolysis: a French population-based study47
Atypical melanocytes of an atypical Spitz tumour observed with optical super-high magnification dermoscopy47
Seeking new topical therapies in psoriasis46
How to score the impact of treatment on cutaneous neurofibromas in clinical trials44
The association of anxiety with granuloma annulare: a case–control study of the National Institutes of Health ‘All of Us’ research programme44
Delusional infestation – do not be scared!43
0.062095880508423